Vertex Pharmaceuticals Inc. buy UBS Group AG
Start price
26.01.26
/
50%
€398.35
Target price
26.01.27
-
Performance (%)
-1.05%
Price
27.01.26
€394.15
Summary
This prediction is currently active. With a performance of -1.05%, the BUY prediction by UBS_Group_AG is trending in the wrong direction. This prediction currently runs until 26.01.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Vertex Pharmaceuticals Inc. | -1.05% |
| iShares Core DAX® | 1.130% |
| iShares Nasdaq 100 | 1.128% |
| iShares Nikkei 225® | 2.610% |
| iShares S&P 500 | -0.006% |
Comments by UBS_Group_AG for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by UBS_Group_AG for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€379.15
09.12.25
09.12.25
-
09.12.26
09.12.26
3.96%
27.01.26
27.01.26
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€352.60
07.11.25
07.11.25
€473.22
07.11.26
07.11.26
11.78%
27.01.26
27.01.26
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€344.35
05.08.25
05.08.25
€478.40
05.08.26
05.08.26
14.46%
27.01.26
27.01.26
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€459.85
05.11.24
05.11.24
€536.01
05.11.25
05.11.25
-21.69%
06.11.25
06.11.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€459.95
17.10.24
17.10.24
€519.06
17.10.25
17.10.25
-21.84%
18.10.25
18.10.25